Deprescribing for Older Adults After Hospital Discharge in Home Health Care
2 other identifiers
interventional
5
1 country
1
Brief Summary
The purpose of this study is to examine the feasibility of providing a medication optimization program to improve patient health outcomes during the transition from hospital to home. This is because the period after hospital discharge is critical to long-term recovery, overall quality of life, and prevention of future hospitalizations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2022
CompletedFirst Posted
Study publicly available on registry
November 29, 2022
CompletedStudy Start
First participant enrolled
March 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2025
CompletedJuly 16, 2025
July 1, 2025
2.2 years
November 17, 2022
July 10, 2025
Conditions
Outcome Measures
Primary Outcomes (8)
mean time spent on intervention
3 months
number of participants who complete a post intervention survey about feasibility
3 months
Percentage of participants undergoing deprescribing
3 months
Percentage of intervention adherence indicators checked
3 months
Percentage of patients who improve in ability to do things that are important before and after intervention
3 months
Total number of medications used per participant
3 months
Percentage of patients who report a reduction in medication burden
Medication burden will be reported by phone or survey.
3 months
Percentage of participants who report a reduction in medication side effect
Side effects will be collected by phone.
3 months
Study Arms (1)
All Participants
EXPERIMENTALInterventions
The HomeMed intervention is a multidisciplinary deprescribing intervention including home visits and team-based telehealth communication (optional). The components included in the HomeMed intervention include home medication review, medication education and provision of tools to assist the patients with medication administration, assessment of deprescribing targets by a trained geriatric clinical pharmacist, communication with the patient's treating primary care provider about deprescribing recommendation, deprescribing implementation (optional), and deprescribing monitoring (optional). Depending on the patient's treating primary care provider's decision on deprescribing and monitoring, the number of home visits ranges from a minimum of three to more with the entire duration of the intervention ranging from approximately 1 to 3 months.
Eligibility Criteria
You may qualify if:
- years of age and older
- currently hospitalized or having been hospitalized in the previous 2 weeks
- having a discharge disposition of home with a referral to receive HHC services from URMHC, or currently receiving HHC services from URMHC
- taking more than 10 regular medications daily
- having a primary care provider who is in the URMC system
- Ability to self-consent
- English-speaking
You may not qualify if:
- end-of-life prognosis in the following 6 months
- currently receiving hospice care, end-of-life care, or palliative care
- conditions that impact the receipt of the intervention, such as severe cognitive impairment that interferes with the subject's ability to communicate with interventionists;
- substantial difficulties in hearing, vision, and verbal expression that disable the participant from communicating effectively while receiving the HomeMed intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
University of Rochester Medical Center
Rochester, New York, 14642, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor - Department of Medicine, Geriatrics/Aging (SMD)
Study Record Dates
First Submitted
November 17, 2022
First Posted
November 29, 2022
Study Start
March 29, 2023
Primary Completion
May 30, 2025
Study Completion
May 30, 2025
Last Updated
July 16, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share